Toxic shock syndrome x ray: Difference between revisions
Jump to navigation
Jump to search
m Changes made per Mahshid's request |
Category |
||
| Line 21: | Line 21: | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
Revision as of 02:52, 22 September 2017
|
Toxic shock syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic shock syndrome x ray On the Web |
|
American Roentgen Ray Society Images of Toxic shock syndrome x ray |
|
Risk calculators and risk factors for Toxic shock syndrome x ray |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview:
On chest x-ray, toxic shock syndrome (TSS) is characterized by diffuse bilateral interstitial and alveolar infiltrates due to ARDS.
CXR
During TSS pulmonary edema and pleural effusion can happen. These can be diagnosed in CXR as diffuse bilateral interstitial and alveolar infiltrates.[1]
References
- ↑ Malghem J, Lecouvet FE, Omoumi P, Maldague BE, Vande Berg BC (2013). "Necrotizing fasciitis: contribution and limitations of diagnostic imaging". Joint Bone Spine. 80 (2): 146–54. doi:10.1016/j.jbspin.2012.08.009. PMID 23043899.